Inicio > PASTOR JIMENO, JOSE CARLOS

PASTOR JIMENO, JOSE CARLOS

PROFESOR EMERITO
Grupo de Retina
 

Índice H en Scopus: 30
 

[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80540]], camposKey:0365-6691 2023-05-01 Artificial Intelligence and new language models in Ophthalmology: Complications of the use of silicone oil in vitreoretinal surgery Integrando la Inteligencia Artificial y los nuevos modelos de lenguaje en Oftalmología: Complicaciones del uso del aceite de silicona en cirugía vítreo-retiniana298303, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78322]], camposKey:0365-6691 2023-01-01 AlaOcta, la historia toca a su fin365366, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78272]], camposKey:0365-6691 2023-01-01 Integrando la Inteligencia Artificial y los nuevos modelos de lenguaje en Oftalmología: Complicaciones del uso del aceite de silicona en cirugía vítreo-retiniana298303, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81075]], camposKey:2673-3080 2023-01-01 Mercury intoxication and ophthalmic involvement: An update review00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78273]], camposKey:0365-6691 2023-01-01 Respuesta de los autores: Integrando la Inteligencia Artificial y los nuevos modelos de lenguaje en Oftalmología: Complicaciones del uso del aceite de silicona en cirugía vítreo-retiniana488489, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72043]], camposKey:0014-4835 2022-06-01 Hair cortisol level as a molecular biomarker in retinitis pigmentosa patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72047]], camposKey:1662-5129 2022-02-11 Programmed Cell Death and Autophagy in an in vitro Model of Spontaneous Neuroretinal Degeneration00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66604]], camposKey:0721-832X 2022-01-01 Acute intraocular toxicity caused by perfluorocarbon liquids: safety control systems of medical devices00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76022]], camposKey:2666-7568 2022-01-01 Grand Challenges in global eye health: a global prioritisation process using Delphi method00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73345]], camposKey:0365-6691 2022-01-01 ¿Que cuesta el índice H?601602, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72049]], camposKey:2164-2591 2021-12-01 Ex-Vivo Method to Quantifiably Evaluate the Staining Effectiveness of Anterior Lens Capsule Dyes00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66835]], camposKey:0721-832X 2021-04-01 Safety of perfluorocarbon liquids cannot be the retinologist¿s responsibility10711072, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65214]], camposKey:2045-2322 2021-01-12 Intraocular toxicity caused by MEROCTANE perfluorocarbon liquid00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66355]], camposKey:1755-375X 2021-01-01 Complications associated with the use of silicone oil in vitreoretinal surgery: A systemic review and meta-analysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=63927]], camposKey:1888-4296 2021-01-01 Impact of contact lens wear on epithelial alterations in keratoconus3743, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=63940]], camposKey:0365-6691 2021-01-01 La ley del péndulo en los productos sanitarios453454, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65165]], camposKey:1177-5467 2021-01-01 Oct variability prevents their use as robust biomarkers in multiple sclerosis20252036, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72050]], camposKey:2073-4409 2021-01-01 Rho-kinase inhibitors for the treatment of refractory diabetic macular oedema00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66836]], camposKey:0721-832X 2021-01-01 Silicone oil safety is not only a purity question269270, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65911]], camposKey:1687-966X 2020-06-27 Mesenchymal Stem Cell Secretome Enhancement by Nicotinamide and Vasoactive Intestinal Peptide: A New Therapeutic Approach for Retinal Degenerative Diseases00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72052]], camposKey:2329-0501 2020-06-12 Human Mesenchymal Stem Cell Secretome Exhibits a Neuroprotective Effect over In Vitro Retinal Photoreceptor Degeneration11551166, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=51256]], camposKey:0273-2300 2020-01-01 Chemical compounds causing severe acute toxicity in heavy liquids used for intraocular surgery1045270, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52925]], camposKey:1177-5467 2020-01-01 Evaluation of Potential Pain Biomarkers in Saliva and Pain Perception After Corneal Advanced Surface Ablation Surgery613623, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65085]], camposKey:2090-004X 2020-01-01 Histological Patterns of Epithelial Alterations in Keratoconus00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66397]], camposKey:1661-6596 2020-01-01 Matrix metalloproteinases in age-related macular degeneration (Amd)132, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52803]], camposKey:1743-0003 2020-01-01 Visual processing speed in hemianopia patients secondary to acquired brain injury: a new assessment methodology00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71254]], camposKey:0146-0404 2019-07-01 Impact of Contact Lens Wear on Epithelial Alterations in Keratoconus00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71255]], camposKey:0146-0404 2019-07-01 Mesenchymal stem cells conditioned medium produced on nicotinamide and/or vasoactive intestinal peptide action improve antioxidative/neuroprotective properties in vitro00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71253]], camposKey:0146-0404 2019-07-01 Meta-Analysis of the rs243865 MMP-2 Polymorphism and Age Related Macular Degeneration Risk00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71256]], camposKey:0146-0404 2019-07-01 Perceived Stress and Biomarkers in Retinitis Pigmentosa00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43077]], camposKey:0007-1161 2019-01-01 Acute retinal toxicity associated with a mixture of perfluorooctane and perfluorohexyloctane: Failure of another indirect cytotoxicity analysis4954, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49601]], camposKey:0365-6691 2019-01-01 Author's reply Réplica del autor100, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43073]], camposKey:0146-0404 2019-01-01 Chemical considerations regarding the H-value methodology and its relation with toxicity determination33633364, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53048]], camposKey:0146-0404 2019-01-01 Clinical characteristics of proven acute intraocular toxicity by perfluorocarbon liquids (PFCL) used in retinal surgery00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53049]], camposKey:0146-0404 2019-01-01 Cytotoxicity evaluation of toxic substances identified in recent reported toxic lots of perfluorocarbon liquids used in intraocular surgery in patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55197]], camposKey:0365-6691 2019-01-01 El escándalo de los productos sanitarios y el problema de los perfluorocarbonados líquidos105106, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53047]], camposKey:0146-0404 2019-01-01 Low Visual Pathway Alterations and Neurological Toxic Effects after Acute Mercury Poisoning in Zinc Manufacturer Workers00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49599]], camposKey:0014-4835 2019-01-01 Mesenchymal stem cells provide paracrine neuroprotective resources that delay degeneration of co-cultured organotypic neuroretinal cultures00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=51254]], camposKey:1932-6203 2019-01-01 Meta-Analysis of the rs243865 MMP-2 Polymorphism and Age Related Macular Degeneration Risk02136240, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56652]], camposKey:0146-0404 2019-01-01 Ocular Surface Pathology in Patients Suffering from Acute Intoxication with Occupational Mercury00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55198]], camposKey:0365-6691 2019-01-01 Resultados de la cirugía de la catarata en un hospital docente de tercer nivel: Más allá del simple número523528, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49597]], camposKey:0365-6691 2019-01-01 Results of cataract surgery in a third-level teaching hospital. More than just a simple number Resultados de la cirugía de la catarata en un hospital docente de tercer nivel. Más allá del simple número523528, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55199]], camposKey:0365-6691 2019-01-01 Sensacionalismo y revistas científicas de referencia417418, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49598]], camposKey:0365-6691 2019-01-01 Sensationalism and leading scientific journals Sensacionalismo y revistas científicas de referencia417418, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49600]], camposKey:0365-6691 2019-01-01 The health products scandal and the problem of perfluorocarbon fluids El escándalo de los productos sanitarios y el problema de los perfluorocarbonados líquidos105106, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71262]], camposKey:0146-0404 2018-07-01 Mesenchymal stem cells reduce neuroretinal degeneration in vitro00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49606]], camposKey:0721-832X 2018-01-01 Biocompatibility of intravitreal injection of human mesenchymal stem cells in immunocompetent rabbits125134, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11666]], camposKey:2045-2322 2018-01-01 Comparison between direct contact and extract exposure methods for PFO cytotoxicity evaluation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49605]], camposKey:1177-5467 2018-01-01 Immunohistochemical assay for neuron-specific enolase, synaptophysin, and RB-associated protein as a diagnostic aid in advanced retinoblastomas11711179, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49604]], camposKey:0028-0836 2018-01-01 Lens regeneration in children00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49602]], camposKey:0365-6691 2018-01-01 Plagiarism in publications Plagio en las publicaciones571572, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55194]], camposKey:0365-6691 2018-01-01 Plagio en las publicaciones571572, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49603]], camposKey:0030-3755 2018-01-01 Retinal toxicity of medical devices used during vitreoretinal surgery: A critical overview236243, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52974]], camposKey:0146-0404 2018-01-01 Toxicity of an endotamponade made by a mixture of perfluorooctane and perfluorohexyloctane evaluated by a new cytotoxicity method00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53201]], camposKey:0146-0404 2018-01-01 Variation of potential pain biomarkers in saliva of patients after Advanced Surface Ablation (ASA) refractive technique00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39306]], camposKey:0146-0404 2017-06-01 Acute retinal toxic damage by AlaOcta (R) a liquid perfluorooctane liquid used in retinal detachment surgery. Clinical picture and functional consequences00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71270]], camposKey:0146-0404 2017-06-01 Evaluation of neurotrophic factors secreted by mesenchymal stem cells in co-culture with porcine neuroretinas00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71271]], camposKey:0146-0404 2017-06-01 Histological Patterns of Epithelial Alteration in Keratoconus00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10084]], camposKey:0275-004X 2017-01-01 Acute retinal damage after using a toxic perfluoro-octane for vitreo-retinal surgery11401151, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52640]], camposKey:1755-375X 2017-01-01 Effects of plasma kallikrein inhibitors in an in vitro RPE oxidative stress model00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49607]], camposKey:1177-5467 2017-01-01 Functional characterization of rs2229094 (T>C) Polymorphism in the tumor necrosis factor locus and lymphotoxin alpha expression in human retina: The Retina 4 project973981, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11457]], camposKey:0148-5598 2017-01-01 mHealth App for iOS to Help in Diagnostic Decision in Ophthalmology to Primary Care Physicians00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49608]], camposKey:1177-5467 2017-01-01 Pain perception description after advanced surface ablation647655, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39307]], camposKey:0146-0404 2017-01-01 Perfluoro-n-octane cytotoxicity in human retinal pigment epithelial cell culture00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39308]], camposKey:0146-0404 2017-01-01 Perfluoro-n-octane cytoxicity in porcine neuroretina organotypic culture00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11554]], camposKey:0271-3683 2017-01-01 Reading Performance Improvements in Patients with Central Vision Loss without Age-Related Macular Degeneration after Undergoing Personalized Rehabilitation Training12601268, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11667]], camposKey:0365-6691 2017-01-01 The acute toxicity problem with some perfluorooctanes El problema de la toxicidad aguda de algunos perfluoro-octanos455457, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71272]], camposKey:1043-0342 2016-11-01 Preclinical safety and feasibility of intraocular injection of human mesenchymal stem cells in immunocompetent pigmented-rabbit00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74459]], camposKey:1090-0535 2016-03-25 A novel coculture model of porcine central neuroretina expiants and retinal pigment epithelium cells243253, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=35035]], camposKey:1090-0535 2016-03-25 A novel coculture model of porcine central neuroretina explants and retinal pigment epithelium cells243253, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11466]], camposKey:0148-5598 2016-01-01 A mobile decision support system for red eye diseases diagnosis: experience with medical students00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=51252]], camposKey:1090-0535 2016-01-01 A novel coculture model of porcine central neuroretina explants and retinal pigment epithelium cells243253, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49610]], camposKey:2090-004X 2016-01-01 Classifications for Proliferative Vitreoretinopathy (PVR): An Analysis of Their Use in Publications over the Last 15 Years00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52639]], camposKey:1948-0210 2016-01-01 Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials376383, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10049]], camposKey:0030-3755 2016-01-01 Perfluorocarbon Liquids Toxicity: A Sanitary Alert6363, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49609]], camposKey:1350-9462 2016-01-01 Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences125155, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46977]], camposKey:1932-6203 2016-01-01 Reliability of Potential Pain Biomarkers in the Saliva of Healthy Subjects: Inter-Individual Differences and Intersession Variability00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10068]], camposKey:0146-0404 2016-01-01 Visual alterations in a cohort of young male patients with acute/subacute intoxication with mercury vapor00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71275]], camposKey:0146-0404 2015-06-01 A NEW METHOD FOR IMPROVING STEM CELLS OBTAINMENT FROM THE PORCINE CILIARY BODY00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71278]], camposKey:0146-0404 2015-06-01 Intravitreal mesenchymal stem cells are safe and well-tolerated in pigmented-rabbit eyes00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71276]], camposKey:0146-0404 2015-06-01 Ophthalmia Neonatorum (ON) in Angola: Results of the first attempt to develop a prophylaxis program00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71277]], camposKey:0146-0404 2015-06-01 Retinal pigment epithelium cells protect neuroretina from spontaneous degenerative modifications in a porcine co-culture model00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49615]], camposKey:0161-6420 2015-01-01 Association between SNPs of metalloproteinases and prostaglandin f2alpha receptor genes and latanoprost response in open-angle glaucoma10401048, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49611]], camposKey:1755-375X 2015-01-01 BAX and BCL-2 polymorphisms, as predictors of proliferative vitreoretinopathy development in patients suffering retinal detachment: The Retina 4 project00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10820]], camposKey:1120-6721 2015-01-01 Coats disease in a patient with Fanconi anemia: a case report182183, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39119]], camposKey:2090-004X 2015-01-01 First attempt to implement ophthalmia neonatorum prophylaxis in Angola: Microorganisms, efficacy, and obstacles00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10093]], camposKey:2090-004X 2015-01-01 Loss of Visual Acuity after Successful Surgery for Macula-On Rhegmatogenous Retinal Detachment in a Prospective Multicentre Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49612]], camposKey:1177-5467 2015-01-01 Ocular pain and discomfort after advanced surface ablation: An ignored complaint16251632, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10104]], camposKey:0007-1161 2015-01-01 Predicting proliferative vitreoretinopathy: temporal and external validation of models based on genetic and clinical variables4148, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49613]], camposKey:2090-004X 2015-01-01 Safety and Biocompatibility of a New High-Density Polyethylene-Based Spherical Integrated Porous Orbital Implant: An Experimental Study in Rabbits00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49614]], camposKey:1080-6040 2015-01-01 Vertical transmission of bacterial eye infections, angola, 2011-2012471473, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39311]], camposKey:0146-0404 2015-01-01 WAVEFRONT ANALYSIS OF HIGHER-ORDER ABERRATIONS IN PATIENTS WITH HIGH MYOPIA00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71273]], camposKey:1755-375X 2014-09-01 BAX and BCL-2 genes in patients with Retinal Detachment with and without Proliferative Vitreoretinopathy. The Retina 4 project00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71274]], camposKey:1755-375X 2014-09-01 Funcionality characterization of RS2229094 (T>C) polymorphism and LT[Alpha] expression in human retinas00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71267]], camposKey:0146-0404 2014-04-01 A Triple-layer Co-culture Model Of Neuroretina, RPE And Adipose-MSCs To Evaluate Cell Therapy In Retinal Degeneration00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71266]], camposKey:0146-0404 2014-04-01 An organotypic culture model of porcine neuroretina supplemented with porcine retinal pigment epithelium (pRPE) cells to simulate an ex vivo subretinal space00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71269]], camposKey:0146-0404 2014-04-01 BAX and BCL-2 genes in patients with Retinal Detachment with and without Proliferative Vitreoretinopathy. The Retina 4 project.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71265]], camposKey:0146-0404 2014-04-01 Functionality Characterization of rs2229094 (T > C) polymorphism and LT alpha Expression in Human Retinas00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71268]], camposKey:0146-0404 2014-04-01 Human adipose tissue derived mesenchymal stem cells (hAD-MSCs) together with different combinations of factors delay the degeneration of human neuroretina in indirect co-culture system00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=50771]], camposKey:2211-5420 2014-01-01 Basement membrane promotes ciliary body derived cell spheres formation112118, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=7594]], camposKey:1549-3296 2014-01-01 Bioactive substrates for human retinal pigment epithelial cell growth from elastin-like recombinamers639646, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49616]], camposKey:2314-6133 2014-01-01 Chitosan feasibility to retain retinal stem cell phenotype and slow proliferation for retinal transplantation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71279]], camposKey:0030-3755 2014-01-01 Genetics of PVR and RD2829, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52812]], camposKey:1869-5760 2014-01-01 The value of simple microbiological studies for on-site screening of acute neonatal conjunctivitis in Angola00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6905]], camposKey:0302-766X 2014-01-01 Triple-layered mixed co-culture model of RPE cells with neuroretina for evaluating the neuroprotective effects of adipose-MSCs705716, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71263]], camposKey:0146-0404 2013-06-01 Distribution of MDM2 T309G polymorphism in European patients with Proliferative Vitreoretinopathy. Retina 4 project00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53606]], camposKey:0146-0404 2013-06-01 Predictive Factors of Reading Performance Post Reading Rehabilitation Program in Central Field Loss Patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71264]], camposKey:0146-0404 2013-06-01 TNF alpha spontaneously secreted in an organotypic culture of porcine neuroretina is blocked by adalimumab00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71281]], camposKey:0146-0404 2013-03-01 A Genetic Case-Control Study Confirms the Implication of SMAD7 and TNF Locus in the Development of Proliferative Vitreoretinopathy (vol 54, pg 1665, 2013)20602060, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10103]], camposKey:0146-0404 2013-01-01 A Genetic Case-Control Study Confirms the Implication of SMAD7 and TNF Locus in the Development of Proliferative Vitreoretinopathy16651678, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=35038]], camposKey:1090-0535 2013-01-01 Adalimumab (tumor necrosis factor-blocker) reduces the expression of glial fibrillary acidic protein immunoreactivity increased by exogenous tumor necrosis factor alpha in an organotypic culture of porcine neuroretina894903, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13970]], camposKey:0213-3911 2013-01-01 Adipose derived mesenchymal stem cells partially rescue mitomycin C treated ARPE19 cells from death in co-culture condition15771583, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10393]], camposKey:0161-6420 2013-01-01 Design and Evaluation of a Customized Reading Rehabilitation Program for Patients with Age-related Macular Degeneration151159, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10098]], camposKey:0275-004X 2013-01-01 External validation of existing formulas to predict the risk of developing proliferative vitreoretinopathy: The retina 1 project; Report 515191527, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49619]], camposKey:0365-6691 2013-01-01 Eye pathology, an ophthalmology thematic network service platform of the Carlos III Health Institute (Instituto de Salud Carlos III) La patología ocular, una plataforma de servicios de la Red Temática de Oftalmología del Instituto de Salud Carlos III205206, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=694]], camposKey:0732-8893 2013-01-01 Fatal disseminated Scedosporium prolificans infection initiated by ophthalmic involvement in a patient with acute myeloblastic leukemia375378, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38600]], camposKey:0022-1759 2013-01-01 Flow cytometry assessment of the purity of human retinal pigment epithelial primary cell cultures6168, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46941]], camposKey:0161-6420 2013-01-01 Intravitreal bevacizumab in myopic neovascular membranes: 24-month results00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55196]], camposKey:0365-6691 2013-01-01 La patología ocular, una plataforma de servicios de la Red Temática de Oftalmología del Instituto de Salud Carlos III205206, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52813]], camposKey:1699-8855 2013-01-01 Ocular Pathology La anatomía patológica ocular220221, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49617]], camposKey:0002-9394 2013-01-01 Regional practice patterns for retinal detachment repair in the United States206207, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10101]], camposKey:0161-6420 2013-01-01 The p53 Codon 72 Polymorphism (rs1042522) Is Associated with Proliferative Vitreoretinopathy The Retina 4 Project623628, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10102]], camposKey:1932-6203 2013-01-01 The T309G MDM2 Gene Polymorphism Is a Novel Risk Factor for Proliferative Vitreoretinopathy00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52947]], camposKey:0146-0404 2013-01-01 Visual loss in retinal detachment and macula-on after successful surgery, Retina 1 project00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10092]], camposKey:1120-6721 2012-01-01 A propensity score matching application: indications and results of adding scleral buckle to vitrectomy: The Retina 1 Project: Report 3244253, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71282]], camposKey:0030-3755 2012-01-01 Main Session 2: PVR and Retinal Detachment77, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=35037]], camposKey:0014-4835 2012-01-01 Time course modifications in organotypic culture of human neuroretina2638, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52969]], camposKey:2090-5688 2012-01-01 Variations in Functional and Anatomical Outcomes and in Proliferative Vitreoretinopathy Rate along a Prospective Collaborative Study on Primary Rhegmatogenous Retinal Detachments: The Retina 1 Project-Report 4.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41667]], camposKey:1947-315X 2011-01-01 Discrete portable measuring device for monitoring noninvasive intraocular pressure with a nano-structured sensing contact lens prototype119, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=317]], camposKey:1549-3296 2011-01-01 Elastin-like recombinamers as substrates for retinal pigment epithelial cell growth243250, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54740]], camposKey:1755-375X 2011-01-01 Evaluation of human retinal pigment epithelial cells growth on elastin-like recombinamers substrates00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46943]], camposKey:0161-6420 2011-01-01 Myopic choroidal neovascularization25212523, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9489]], camposKey:0924-4247 2011-01-01 Non-invasive intraocular pressure monitoring with a contact lens engineered with a nanostructured polymeric sensing film3643, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9490]], camposKey:0146-0404 2011-01-01 Prototype of a Nanostructured Sensing Contact Lens for Noninvasive Intraocular Pressure Monitoring83108315, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11669]], camposKey:1177-5467 2011-01-01 Training and professional profile of retinologists in Spain: Retina 2 project, Report 4483490, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38602]], camposKey:0014-4835 2011-01-01 Trypan Blue staining method for quenching the autofluorescence of RPE cells for improving protein expression analysis956962, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56655]], camposKey:0146-0404 2010-04-01 Neuroretinal Reactive Gliosis is Not Appreciable If Macrophage-Like Cells Do Not Produce TNF Alpha and/or IL-1b. Preliminary Results00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10096]], camposKey:0161-6420 2010-01-01 A Strong Genetic Association between the Tumor Necrosis Factor Locus and Proliferative Vitreoretinopathy: The Retina 4 Project24172423, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53689]], camposKey:0146-0404 2010-01-01 Noninvasive Intraocular Pressure Monitorization With a Sensing Contact Lens5700, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49620]], camposKey:1699-8855 2010-01-01 Reflections on the pathology of the eye Reflexiones sobre la patología ocular5758, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43544]], camposKey:0365-6691 2010-01-01 Reflexiones sobre la patología ocular5758, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49621]], camposKey:0365-6691 2010-01-01 Reflexionts on ocular pathology Reflexiones sobre la patología ocular5758, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52831]], camposKey:1825-0572 2009-01-01 Cell therapies for dry forms of age-related macular degeneration: Therapeutic alternatives are currently in development for atrophic AMD7375, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49622]], camposKey:0146-0404 2009-01-01 Development of predictive models of proliferative vitreoretinopathy based on genetic variables: The retina 4 project23842390, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46945]], camposKey:0365-6691 2009-01-01 Efficacy and safety of intravitreal injection of triamcinolone acetonide as treatment for diffuse diabetic macular edema Evaluación de la eficacia y seguridad de la inyección intravítrea de acetónido de triamcinolona en el tratamiento del edema de mácula difuso del diabético547548, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55185]], camposKey:0365-6691 2009-01-01 Evaluación de la eficacia y seguridad de la inyección intravítrea de acetónido de triamcinolona en el tratamiento del edema de mácula difuso del diabético547548, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11671]], camposKey:0365-6691 2009-01-01 Formación y actividad clínica de los retinólogos en españa: Un primer acercamiento. Proyecto retina 2. Análisis descriptivo Training and clinical activity of Spanish retinologists: A preliminary approach. Retina 2 project. Descriptive analysis7584, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53042]], camposKey:0146-0404 2008-01-01 Anatomical and Functional Outcomes After Surgery for Primary Rhegmatogenous Retinal Detachments (RD) in Phakic and Pseudophakic Patients. Preliminary Results of a Multicentric Prospective Study: The Retina 1 Project52405240, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10072]], camposKey:0275-004X 2008-01-01 Diagnostic and therapeutic challenges174179, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=35039]], camposKey:1090-0535 2008-01-01 Muller and macrophage-like cell interactions in an organotypic culture of porcine neuroretina21482156, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10069]], camposKey:0007-1161 2008-01-01 Non-complicated retinal detachment management: variations in 4 years. Retina 1 project; report 1523525, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37435]], camposKey:0275-004X 2008-01-01 Solubility of triamcinolone acetonide and other anti-inflammatory drugs in silicone oil implications for therapeutic efficacy12471250, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10090]], camposKey:0007-1161 2008-01-01 Surgical outcomes for primary rhegmatogenous retinal detachments in phakic and pseudophakic patients: the Retina 1 Project - report 2378382, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53053]], camposKey:0146-0404 2008-01-01 Training Reading Performance Might Improve Depression in Low Vision Patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43049]], camposKey:0365-6691 2007-01-01 Corrección de anisometropía tras cirugía de desprendimiento de retina y LASIK501504, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41671]], camposKey:0365-6691 2007-01-01 Correction of secondary anisometropia after retinal detachment and LASIK surgery Corrección de anisometropía secundaria tras cirugía de desprendimiento de retina y LASIK501503, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49624]], camposKey:0002-9394 2007-01-01 Lipophilic Substances in Intraocular Silicone Oil707709, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55202]], camposKey:0365-6691 2007-01-01 Manejo de los desprendimientos de retina regmatógenos urgentes en el Sistema Nacional de Salud de España: Proyecto Retina 2279284, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49623]], camposKey:0365-6691 2007-01-01 Urgent retinal detachment management by the National Health System of Spain. project retina 2 Manejo de los desprendimientos de retina regmatógenos urgentes en el Sistema Nacional de Salud de España. Proyecto retina 2279284, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37436]], camposKey:0365-6691 2006-01-01 Cholesterol, alpha-tocopherol, and retinoid concentrations in silicone oil used as a vitreous substitute1320, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13965]], camposKey:0365-6691 2006-01-01 Concentraciones de colesterol, ¿-tocoferol y retinoides en aceite de silicona tras su utilizaci¿n como sustitutivo vítreo1319, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39632]], camposKey:1395-3907 2006-01-01 Cytokine gene polymorphisms in retinal detachment patients with and without proliferative vitreoretinopathy: a preliminary study309313, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55201]], camposKey:0365-6691 2006-01-01 Encuesta nacional sobre la cirugía vítreo-retiniana y la atención de los desprendimientos de retina regmatógenos en España: Proyecto Retina 2635640, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49626]], camposKey:0365-6691 2006-01-01 Independent clinical research: It's possible Investigación clínica independiente: Es posible133134, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10091]], camposKey:0030-3747 2006-01-01 Intraretinal immunohistochemistry findings in proliferative vitreoretinopathy with retinal shortening193200, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55192]], camposKey:0365-6691 2006-01-01 Investigación clínica independiente: es posible133134, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49625]], camposKey:0365-6691 2006-01-01 National survey on vitreo-retinal surgery and the management of rhegmatogenous retinal detachments in Spain. Project retina 2 Encuesta nacional sobre la cirugía vítreoretiniana y la atención de los desprendimientos de retina regmatógenos en españa. Proyecto retina 2635640, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71261]], camposKey:0048-8143 2005-04-01 Mou Zongsan (1905-1995) and his problematic recourse to Taoism247266, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39634]], camposKey:0146-0404 2005-01-01 Cytokine gene polymorphism in retinal detachment patients with and without proliferative vitreoretinopathy preliminary study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55189]], camposKey:0365-6691 2005-01-01 El Instituto de Salud Carlos III, financia un ensayo clínico sobre triamcinolona a la Red Temática de Investigación Cooperativa6969, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10387]], camposKey:0271-3683 2005-01-01 Interaction between surgical procedure for repairing retinal detachment and clinical risk factors for proliferative vitreoretinopathy147153, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49627]], camposKey:0365-6691 2005-01-01 The Health Institute Carlos III supports a clinical trial on triamcinolone as part of the Eye Research Network El Instituto de Salud Carlos III, financia un ensayo clínico sobre triamcinolona a la Red Temática de Investigación Cooperativa.690, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49628]], camposKey:0365-6691 2004-01-01 Are we Spanish ophthalmologists good scientists? (Wisen up. [you jerk]... or they'll eat us for breakfast!) Somos buenos científicos los oftalmólogos Españoles? (Espabila. [huevón]... que te comen la merienda!).313314, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11676]], camposKey:0365-6691 2004-01-01 Corneal epithelial complications after vitrectomy: a retrospective study Complicaciones corneales epiteliales de las vitrectomías: estudio retrospectivo.155161, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13967]], camposKey:0365-6691 2004-01-01 Estudio experimental sobre la utilidad del aceite de copolímero de silicona-fluorsilicona (SiFO) en la cirugía vitreorretiniana205212, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49631]], camposKey:0365-6691 2004-01-01 Experimental study on usefulness of silicone-fluorsilicone copolymer oil (SiFO) in vitreoretinal surgery Estudio experimental sobre la utilidad del aceite de copolímero de silicona-fluorsilicona (SiFO) en la cirugía vitreorretiniana.205212, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13966]], camposKey:0365-6691 2004-01-01 Melanocitoma de cuerpo ciliar sintomático: glaucoma melanocitomalítico511514, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13959]], camposKey:0365-6691 2004-01-01 Oftalmía simpática postvitrectomía tras traumatismo y taponamiento con perfluorocarbono líquido553556, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55186]], camposKey:0365-6691 2004-01-01 ¿Somos buenos científicos los oftalmólogos españoles?: [¡Espabila... (huevón)... que te comen la merienda!]313314, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49629]], camposKey:0365-6691 2004-01-01 Sympathetic ophthalmia post-vitrectomy following trauma and perfluorocarbon liquid tamponade Oftalmía simpática postvitrectomía tras traumatismo y taponamiento con perfluorocarbono líquido.553556, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49630]], camposKey:0365-6691 2004-01-01 Symptomatic ciliary body melanocytoma: melanocytomalytic glaucoma Melanocitoma de cuerpo ciliar sintomático: glaucoma melanocitomalítico.511514, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49633]], camposKey:0365-6691 2003-01-01 Can the use of intraocular silicone oil increase the risk of sympathetic ophthalmia? ¿Puede aumentar el riesgo de oftalmía simpática el uso intraocular de aceite de silicona?3942, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10075]], camposKey:0146-0404 2003-01-01 Clinical and surgical features of retinal shortening: The most severe and less recognized form of proliferative vitreoretinopathy (PVR)29790, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49634]], camposKey:0365-6691 2003-01-01 Clinical risk factors for postoperative proliferative vitreoretinopathy (PVR). A prospective study Factores clínicos de riesgo para el desarrollo de la vitreorretinopatía proliferante (VRP) postquirúrgica. Estudio prospectivo.9197, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55184]], camposKey:0365-6691 2003-01-01 Factores clínicos de riesgo para el desarrollo de la vitreorretinopatía proliferante (VRP) postquirúrgica: Estudio prospectivo9197, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13962]], camposKey:0365-6691 2003-01-01 Grupo control para aminoácidos en el vítreo241242, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10380]], camposKey:0030-3747 2003-01-01 Proliferative vitreoretinopathy: Cytologic findings in vitreous samples232238, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13969]], camposKey:0365-6691 2003-01-01 ¿Puede aumentar el riesgo de oftalmía simpática el uso intraocular de aceite de silicona?3942, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11677]], camposKey:0365-6691 2003-01-01 Retinal shortening: the most severe form of proliferative vitreoretinopathy (PVR). Acortamiento retiniano: la forma más grave de la vitreorretinopatía proliferante (VRP).653657, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13961]], camposKey:0365-6691 2003-01-01 Roturas retinianas iatrogénicas en las vitrectomías: estudio retrospectivo487491, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49632]], camposKey:0365-6691 2003-01-01 Vitreous body amino acids control group Grupo control para aminoácidos en el vítreo.241242, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71283]], camposKey:0146-0404 2002-05-01 Incidence of diabetic retinopathy in a rural population of Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44393]], camposKey:0365-6691 2002-01-01 Actividad de los enzimas glutation-dependientes durante la vitrectomía: Efecto de la solución BSS Plus en retina133138, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54887]], camposKey:0030-3747 2002-01-01 Antisilicone antibodies in patients with silicone implants for retinal detachment surgery - Reply106106, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10382]], camposKey:0146-0404 2002-01-01 Chronobiology of proliferative vitreoretinopathy (PVR). A cytological study of 133 vitreous samples00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10383]], camposKey:0146-0404 2002-01-01 Clinical risk factors of proliferative vitreoretinopathy (PVR). A case-control and multicentric study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43961]], camposKey:0365-6691 2002-01-01 Detección de células fantasma en citologías vítreas: Correlación clínico-patológica369376, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49636]], camposKey:0365-6691 2002-01-01 Ghost cell detection in vitreous cytology: clinico-pathological correlation Detección de células fantasma en citologías vítreas: correlación clínico-patológica.369375, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37437]], camposKey:0365-6691 2002-01-01 Glutathione-related enzymes activity during vitrectomy. Effect of BSS Plus(R) in retinal tissue Actividad de los enzimas glutation-dependientes durante la vitrectomía. Efecto de la solución BSS Plus(R) en retina.133138, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=1818]], camposKey:0014-4835 2002-01-01 Oral flavonoids, chromocarb diethylamine salt and cyaninosides chloride, to eliminate lipoperoxidation postvitrectomy2328, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41649]], camposKey:0928-6586 2002-01-01 Prevalence of diabetic retinopathy and eye care in a rural area of Spain205214, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49635]], camposKey:1350-9462 2002-01-01 Proliferative vitreoretinopathy: Risk factors and pathobiology127144, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=8812]], camposKey:0146-0404 2002-01-01 Study of the efficacy of a new electronic device for the ARMD: A new therapeutic option00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10376]], camposKey:0146-0404 2002-01-01 What is the cause of the impaired color vision in diabetic patients?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71285]], camposKey:0146-0404 2001-03-15 Detection of activated macrophages in vitreous samples from patients with proliferative vitreoretinopathy (PVR) by in situ non-radioactive Southwestern histochemistry.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54147]], camposKey:0146-0404 2001-03-15 Is silicone oil intraocularly injected related to a higher prevalence of sympathetic ophthalmia?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71286]], camposKey:0146-0404 2001-03-15 Systemic therapy with adenovirus dl118 in an experimental uveal melanoma.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3564]], camposKey:0365-6691 2001-01-01 Acute macular neuroretinopathy: a case report Neuro-retinopatía macular aguda: a propósito de un caso.319322, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49471]], camposKey:0030-3747 2001-01-01 Antisilicone antibodies in patients with silicone implants for retinal detachment surgery8790, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49644]], camposKey:0365-6691 2001-01-01 Comparison of different techniques for cytologic analysis of vitreous specimens Comparación de diferentes técnicas de análisis citológico en muestras vítreas.723730, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49641]], camposKey:0365-6691 2001-01-01 Efficacy of direct paraffin embedding in cytological analysis of vitreous from proliferative vitreo-retinopathy (PVR) Eficacia de la inclusión directa en parafina en el estudio citológico del vítreo en pacientes con vitreorretinopatía proliferante (VRP).655660, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49637]], camposKey:1559-128X 2001-01-01 Experimental measurement of corneal haze after excimer laser keratectomy17271734, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9485]], camposKey:1081-597X 2001-01-01 Experimental model of corneal haze in chickens696699, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49642]], camposKey:0365-6691 2001-01-01 Flavonoid drugs as antioxidant in intraocular irrigating solution Flavonoides como antioxidantes en solución de irrigación intraocular.499504, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37438]], camposKey:0365-6691 2001-01-01 Inhibition of lipid peroxidation in retinal tissue during vitrectomy. Effect of intraocular irrigating solution BSS plus Inhibición de la lipoperoxidación retiniana durante la vitrectomía. Efecto de la solución de irrigación intraocular BSS plus.605612, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49639]], camposKey:0365-6691 2001-01-01 Outer retinal edema or multifocal choroiditis after retinal detachment surgery. A case report Edema retiniano externo o coroiditis multifocal tras la cirugía del desprendimiento de retina. A propósito de un caso.379384, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49643]], camposKey:0365-6691 2001-01-01 Progressive diffuse subretinal fibrosis syndrome: a case report Síndrome de fibrosis subretiniana progresiva: a propósito de un caso.259262, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49640]], camposKey:0365-6691 2001-01-01 Treatment of the massive suprachoroidal hemorrhages El tratamiento de las hemorragias supracoroideas masivas.235240, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3565]], camposKey:0365-6691 2001-01-01 Usefulness of conjunctival biopsy as diagnostic technique Utilidad de la biopsia conjuntival como técnica diagnóstica.3136, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71260]], camposKey:0146-0404 2000-03-15 A pilot study of telemidicine in diabetic retinopahthy screening.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71259]], camposKey:0146-0404 2000-03-15 Corneal transparency following mechanical or chemical epithelial debridement in an experimental model of photorefractive keratectomy (PRK).00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71258]], camposKey:0146-0404 2000-03-15 Experimental measurement of forward scattering and quantitative analysis of keratocyte influence in corneal haze after PRK00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71257]], camposKey:0146-0404 2000-03-15 Pars planitis: Epidemiology, treatment, visual outcome and association with multiple sclerosis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40670]], camposKey:0146-0404 2000-01-01 Chitosan modulate corneal wound healing and increase corneal transparency in an experimental model of photorefractive keratectomy (PRK)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41650]], camposKey:0030-3747 2000-01-01 Combined pharmacologic therapy in a rabbit model of proliferative vitreoretinopathy (PVR)2529, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49645]], camposKey:0365-6691 2000-01-01 Diabetic retinopathy in a patient with HIV infection and type A hemophilia Retinopatía diabética en un paciente con infección por VIH y hemofilia tipo A.4750, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10057]], camposKey:1080-7683 2000-01-01 Pharmacokinetics of 0.5 mg of a single and a multiple dose of intravitreal vancomycin in infected rabbit eyes373381, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49646]], camposKey:0365-6691 2000-01-01 Potential to predict the risk of developing proliferative vitreoretinopathy with the analysis of clinical factors of regmatogenous retinal detachments Posibilidad de predecir el riesgo de una vitreorretinopatía proliferante mediante el análisis de factores clínicos de los desprendimientos de retina regmatógenos.807812, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71251]], camposKey:0146-0404 1999-03-15 Antiallergic efficacy of the antiallergic eye drop lodoxamide 0.1% and Naaga 4.9% on ragweed-induced allergic conjunctivitis in mice.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71287]], camposKey:0146-0404 1999-03-15 Evaluation of lectin staining in the diagnosis of mycotic keratitis in an experimental model in the rabbit.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9480]], camposKey:0146-0404 1999-03-15 Objective measurement of corneal haze after excimer laser keratectomy00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71289]], camposKey:0146-0404 1999-03-15 Pharmacological modulation of corneal haze after excimer laser keratectomy00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71290]], camposKey:0146-0404 1999-03-15 Prevalence of primary open angle glaucoma: The Segovia study.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71288]], camposKey:0146-0404 1999-03-15 Two years of diabetic retinopathy and progression risk factors in a rural population of Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43960]], camposKey:0365-6691 1999-01-01 Braquiterapia epiescleral: alternativa terapéutica eficaz en los hemangiomas circunscritos de coroides541544, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46184]], camposKey:0365-6691 1999-01-01 Características de los desprendimientos de retina regmatógenos que se remiten a un hospital de referencia: variaciones en 15 años569573, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46179]], camposKey:0365-6691 1999-01-01 Historias de miopes662662, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39649]], camposKey:0146-0404 1999-01-01 IgG subtypes in serum from patients with antisilicone antibodies (anti-S Ab).00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46180]], camposKey:0365-6691 1999-01-01 Las transformaciones versus las revoluciones11, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46189]], camposKey:0365-6691 1999-01-01 Ophthalmic surgical assistant289289, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71322]], camposKey:1120-6721 1998-07-01 Clinical consequences of the use of highly purified silicone oil - Comparative study of highly and less purified silicons oil179183, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52838]], camposKey:1369-5207 1998-01-01 A double-blind double-dummy comparison of topical lomefloxacin 0.3% twice daily with topical gentamicin 0.3% four times daily in the treatment of acute bacterial conjunctivitis2939, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46175]], camposKey:0365-6691 1998-01-01 A vueltas con la ética de las publicaciones349350, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=774]], camposKey:0277-3740 1998-01-01 Analysis of human ocular mucus: Effects of neuraminidase and chitinase enzymes200207, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37439]], camposKey:1120-6721 1998-01-01 Clinical consequences of the use of highly purified silicone oil: Comparative study of highly and less purified silicone oil179183, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43941]], camposKey:0365-6691 1998-01-01 Efecto de los precursores de glutation en una solución de irrigación sobre los niveles intraoculares de GSH585591, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46186]], camposKey:0365-6691 1998-01-01 El retraso en la publicación6970, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46182]], camposKey:0365-6691 1998-01-01 La ética en las publicaciones297298, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10073]], camposKey:1080-7683 1998-01-01 Pharmacokinetics of intravitreal vancomycin in normal and infected rabbit eyes555563, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49647]], camposKey:0039-6257 1998-01-01 Proliferative vitreoretinopathy: An overview318, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49650]], camposKey:0146-0404 1997-12-01 Does the use of silicone in ophthalmic surgery increase the risk of developing an autoimmune disease?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41436]], camposKey:0146-0404 1997-12-01 Evaluation of chitosan as a substitute for the mucus layer of the preocular tear film00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=720]], camposKey:0721-832X 1997-05-01 Characterization of epithelial primary cultures from human conjunctiva268276, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71296]], camposKey:0146-0404 1997-03-15 Analysis of visual field defects with neural networks.26772677, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71294]], camposKey:0146-0404 1997-03-15 Clinicopathologic correlation of hematologic tumors with primary orbital presentation601601, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71295]], camposKey:0146-0404 1997-03-15 Does the use of silicone in ophthalmic surgery increase the risk of developing an autoimmune disease?31423142, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10426]], camposKey:0146-0404 1997-03-15 Effect of cyclosporine A on the development of experimental choroidal tumors from human uveal melanoma cells in pigmented rabbits37303730, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71293]], camposKey:0146-0404 1997-03-15 Evaluation of chitosan as a substitute for the mucus layer of the preocular tear film646646, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71291]], camposKey:0146-0404 1997-03-15 Evidence of mucin production in cultured conjunctival epithelium757757, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=1817]], camposKey:0146-0404 1997-03-15 Gas chromatography determination of fatty acids in silicone oil used in the treatment of retinal surgery.31413141, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71297]], camposKey:0146-0404 1997-03-15 Incidence and prevalence of diabetic retinopathy (DR) and macular edema in a diabetic rural population of Spain16351635, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10422]], camposKey:0146-0404 1997-03-15 The influence of varying blood levels of Cyclosporin A (CsA) in the development of an experimental model of uveal melanoma in albino rabbits37473747, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71292]], camposKey:0146-0404 1997-03-15 Vitreous levels and efficacy of intravitreal lomefloxacin in the rabbit eye.711711, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49649]], camposKey:0146-0404 1997-01-01 Analysis of visual field defects with neural networks00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49652]], camposKey:0302-9743 1997-01-01 Detection of glaucoma by means of ANNs986994, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3570]], camposKey:0365-6691 1997-01-01 Diagnostic tests of blepharitis-associated dry-eye syndrome. Usefulness of topical anesthesia Test diagnosticos del sindrome de ojo seco asociado a blefaritis, utilidad de la anestesia topica437444, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42610]], camposKey:0365-6691 1997-01-01 Distribución de las uveítis en un centro de referencia665670, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10059]], camposKey:0146-0404 1997-01-01 Efficacy of a new regime of intravitreal vancomycin in the treatment of endophthalmitis rabbit eyes51975197, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41434]], camposKey:0146-0404 1997-01-01 Evidence of mucin production in cultured conjunctival epithelium00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49648]], camposKey:0146-0404 1997-01-01 Gas chromatography determination of fatty acids in s1licone oil used in the treatment of retinal surgery00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=735]], camposKey:0146-0404 1997-01-01 In vitro study on the toxic effects of carbomer-derived versus carboxymethylcellulose (CMC)-derived artificial tear formulations upon corneal cells749749, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=667]], camposKey:0927-3948 1997-01-01 Influence of topical anesthesia on tests diagnostic of blepharitis-associated dry eye syndrome3342, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49651]], camposKey:0271-3683 1997-01-01 Porcine model of proliferative vitreoretinopathy with platelets556563, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43244]], camposKey:0927-3972 1997-01-01 Prevalence of amblyogenic diseases in a preschool population sample of Valladolid, Spain7380, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55200]], camposKey:0365-6691 1997-01-01 Test diagnósticos del síndrome de ojo seco asociado a blefaritis: utilidad de la anestesia tópica437444, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=35026]], camposKey:0271-3683 1997-01-01 The role of retinotomy in an experimental rabbit model of proliferative vitreoretinopathy422427, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42611]], camposKey:0365-6691 1997-01-01 Tinción diferencial mediante lectinas de la capa mucosa de la película lagrimal precorneal y hongos en un modelo animal de queratitis micótica1116, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10385]], camposKey:0161-6420 1997-01-01 Value of logistic discriminant analysis for interpreting initial visual field defects525531, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71298]], camposKey:0042-6989 1996-10-01 Growth of a human uveal melanoma cell line in the choroid of rabbits: A model of local and systemic disease.459459, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71299]], camposKey:0042-6989 1996-10-01 Role of GSSG in irrigating solutions on GSH levels in vitrectomized rabbit eyes358358, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71280]], camposKey:0724-8741 1996-09-01 Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A (vol 13, pg 311, 1996)14231423, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41653]], camposKey:0146-0404 1996-02-15 Combined pharmacological therapy in an experimental model of Proliferative Vitreoretinopathy (PVR)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71304]], camposKey:0146-0404 1996-02-15 Combined pharmacological therapy in an experimental model of proliferative vitreoretinopathy (PVR)18451845, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71302]], camposKey:0146-0404 1996-02-15 Corneal incorporation of exogenous hyaluronic acid on a lamellar keratectomy animal model25342534, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71303]], camposKey:0146-0404 1996-02-15 Determination of fat-soluble compounds in silicone oil used in the treatment of retinal detachments18871887, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37440]], camposKey:0146-0404 1996-02-15 Determination of fat-soluble compounds in silicone oil used in the treatment of retinal detachments00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71306]], camposKey:0146-0404 1996-02-15 Diabetic retinopathy (DR) and patterns of diabetic eye care by primary care physicians in Castilla-Leon, Spain496496, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71305]], camposKey:0146-0404 1996-02-15 Growth of a human weal melanoma cell line in rabbits immunosuppressed with different doses of cyclosporin A (CsA)11081108, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71307]], camposKey:0146-0404 1996-02-15 Nedocromil sodium (NS) modulates ICAM-1 and HLA-DR expression of human conjunctival epithelial cells in vitro226226, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71301]], camposKey:0146-0404 1996-02-15 Pharmacokinetics of a multiple regimen of 0.5 mg of vancomycin in endophthalmic rabbit eyes35733573, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71300]], camposKey:0146-0404 1996-02-15 Treatment of patients with acute bacterial conjunctivitis with Lomefloxacin 0.3% bid or Gentamicin 0.3% qid47454745, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49653]], camposKey:0146-0404 1996-02-15 Treatment of patients with acute bacterial conjunctivitis with lomefloxacin 0.3% b.i.d. or gentamicin 0.3% q.i.d00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41617]], camposKey:0146-0404 1996-01-01 Corneal incorporation of exogenous hyaluronic acid on a lamellar keratectomy animal model00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41654]], camposKey:0146-0404 1996-01-01 Diabetic Retinopathy (DR) and patterns of diabetic eye care by primary care physicians in Castilla-Leon Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42338]], camposKey:0212-6567 1996-01-01 Dry eye syndrome: etiopathology and clinical forms Síndrome de ojo seco: etiopatogenia y formas clínicas.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=709]], camposKey:1081-1206 1996-01-01 Efficacy of nedocromil sodium and cromolyn sodium in an experimental model of ocular allergy124130, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3573]], camposKey:0724-8741 1996-01-01 Erratum: Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A (Pharmaceutical Research, 13(2), 311-315, (1996))14230, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43956]], camposKey:0365-6691 1996-01-01 Estudio citológico del vítreo en las vitrectomías: diferencias entre vitreorretinopatía proliferante y retinopatía diabática proliferante197204, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41438]], camposKey:0146-0404 1996-01-01 Growth of a human uveal melanoma cell line in rabbits immunosuppressed with different doses of cyclosporin A (CsA)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41437]], camposKey:0146-0404 1996-01-01 Nedocromil Sodium (NS) modulates ICAM-1 and HLA-DR expression of human conjunctival epithelial cells in vitro00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40841]], camposKey:0146-0404 1996-01-01 Pharmacokinetics of a multiple regimen of 0.5 mg of vancomycin in endophthalmic rabbit eyes00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=634]], camposKey:0724-8741 1996-01-01 Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A311315, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46952]], camposKey:1022-0178 1995-09-20 Increased ocular corneal uptake of drugs using poly-¿-caprolactone nanocapsules and nanoemulsions322323, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71310]], camposKey:0146-0404 1995-03-15 CAN CONJUNCTIVAL EPITHELIAL-CELLS WORK AS ANTIGEN-PRESENTING CELLS (APCS)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39500]], camposKey:0146-0404 1995-03-15 CHARACTERIZATION OF HUMAN CONJUNCTIVAL EPITHELIAL-CELLS IN CULTURE00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71311]], camposKey:0146-0404 1995-03-15 CLINICAL CONSEQUENCES OF THE USE OF HIGHLY PURIFIED SILICONE OIL00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71312]], camposKey:0146-0404 1995-03-15 COMPLICATIONS ON THE USE OF SIF0 AS A SHORT-TERM RETINAL TAMPONADE IN RETINAL-DETACHMENT SURGERY00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71308]], camposKey:0146-0404 1995-03-15 DIFFERENTIAL STAINING OF MUCUS AND FUNGI IN AN ANIMAL-MODEL OF MYCOTIC KERATITIS00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71314]], camposKey:0146-0404 1995-03-15 GLUTATHIONE CHANGES RELATED TO VITRECTOMY AND INTRAOCULAR IRRIGATING SOLUTIONS IN RABBIT LENS AND RETINA00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71309]], camposKey:0146-0404 1995-03-15 PRESENCE OF MUCUS ON CULTURED CONJUNCTIVAL EPITHELIAL-CELLS TREATED WITH HYDROCORTISONE00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71313]], camposKey:0146-0404 1995-03-15 PREVALENCE OF DIABETIC-RETINOPATHY IN A DIABETIC RURAL-POPULATION OF SPAIN00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43849]], camposKey:0365-6691 1995-01-01 Actividad antagonista del colirio de ibopamina sobre la miosis intraoperatoria203208, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42339]], camposKey:0365-6691 1995-01-01 Activity of ibopamine solution on intraoperative miosis Actividad antagonista del colirio de ibopamina sobre la miosis intraoperatoria203208, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39314]], camposKey:0146-0404 1995-01-01 DISTRIBUTION OF AGE-RELATED LENS OPACITIES IN A SPANISH POPULATION-SAMPLE00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=761]], camposKey:0146-0404 1995-01-01 Effect of the enzymes chitinase and neuraminidase on the structure of human ocular mucus00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46190]], camposKey:0365-6691 1995-01-01 Endoftalmitis crónica por Propionibacterium Acnes tras la extracción extracapsular del cristalino914, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40671]], camposKey:0146-0404 1995-01-01 INTERPRETATION OF GLAUCOMATOUS VISUAL-FIELDS WITH NEURAL NETWORKS00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39317]], camposKey:0146-0404 1995-01-01 INTRAVITREAL PHARMACOKINETICS OF 0.5 AND 1 MG OF VANCOMYCIN IN ENDOPHTHALMIC RABBIT EYES00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=658]], camposKey:0146-0404 1995-01-01 OCULAR PENETRATION OF 1-PERCENT CYCLOSPORINE (CYA) FROM NANOCAPSULES AND CONVENTIONAL FORMATIONS IN RABBIT EYES00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43958]], camposKey:0365-6691 1995-01-01 Papel del factor de crecimiento derivado de las plaquetas (PDGF) en un modelo experimental de VRP en el cerdo123130, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71315]], camposKey:0030-3747 1995-01-01 TOLERANCE OF INTRAVITREOUS INTERLEUKIN-1-BETA IN THE TREATMENT OF EXPERIMENTAL VITREOUS HEMORRHAGE3741, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49654]], camposKey:0030-3747 1995-01-01 Tolerance of intravitreous interleukin-1ß in the treatment of experimental vitreous hemorrhage3741, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40666]], camposKey:0146-0404 1995-01-01 TOPICAL APPLICATION OF NANOCAPSULES OF CYCLOSPORINE-A (CYA) ON A PENETRATING KERATOPLASTY REJECTION MODEL00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10062]], camposKey:0146-0404 1995-01-01 VALUE OF VITREOUS CYTOLOGY IN THE DIAGNOSIS OF VITREORETINAL DISEASES00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10052]], camposKey:0146-0404 1995-01-01 Vitreous levels of lomefloxacin after intravenous injection in the rabbit. Sample extraction with a perfused rabbit eye model00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71319]], camposKey:0146-0404 1994-03-15 APHAKIC PSEUDOPHAKIC CORNEAL EDEMA (A/PCE) - HISTOPATHOLOGIC STUDY17841784, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71316]], camposKey:0146-0404 1994-03-15 COMPUTERIZED ANALYSIS OF VISUAL-FIELDS FOR THE DIAGNOSE OF GLAUCOMATOUS DEFECTS21802180, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71320]], camposKey:0146-0404 1994-03-15 EFFICACY AND OCULAR AND SYSTEMIC TOLERANCE OF INTRAVITREAL INJECTION OF INTERLEUKIN-1-BETA (IL-1-BETA) IN EXPERIMENTAL VITREOUS HEMORRHAGES15341534, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71318]], camposKey:0146-0404 1994-03-15 EXPERIMENTAL-MODEL OF PROLIFERATIVE VITREORETINOPATHY (PVR) WITH PLATELET-RICH PLASM (PRP) - COMPARISON OF THE RESULTS IN RABBITS AND PIGS20392039, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71321]], camposKey:0146-0404 1994-03-15 INHIBITORY EFFECT OF INTRAVITREAL INJECTION OF INTERLEUKIN-4 (IL-4) ON A RABBIT MODEL OF PVR15331533, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71317]], camposKey:0146-0404 1994-03-15 ROLE OF THE PLATELET-DERIVED GROWTH-FACTOR (PDGF) IN THE DEVELOPMENT OF AN EXPERIMENTAL-MODEL OF PORCINE PROLIFERATIVE VITREORETINOPATHY (PVR)20392039, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=776]], camposKey:0146-0404 1994-01-01 Chromatographic purification of human ocular mucus and structural-analysis by enzymatic means17951795, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3574]], camposKey:0365-6691 1994-01-01 Comparative clinical trial of 2% hydroxypropyl-methylcellulose versus 1% sodium hyaluronate in extracapsular surgery ESTUDIO CLINICO COMPARATIVO DE LA HIDROXIPROPIL-METILCELULOSA 2% QUIRURGICA VERSUS HIALURONATO SODICO 1% EN LA CIRUGIA EXTRACAPSULAR DE CATARATA39, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43959]], camposKey:0365-6691 1994-01-01 Creación de un modelo eficaz de VRP127134, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49655]], camposKey:0365-6691 1994-01-01 Efficacy and tolerance of intravitreal injection of interleukine-1 beta (IL-1 ß) in experimental vitreous hemorrhages EFICACIA Y TOLERANCIA DE LA INYECCION INTRAVITREA DE INTERLEUKINA-1 BETA (IL-1 ß) EN HEMORRAGIAS VITREAS EXPERIMENTALES291295, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55190]], camposKey:0365-6691 1994-01-01 Eficacia y tolerancia de la inyección intravitrea de interleukina-1 beta (IL-1ß) en hemorragias vítreas experimentales291296, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43850]], camposKey:0365-6691 1994-01-01 Estudio clínico-comparativo de la hidroxipropil-metilcelulosa 2% quirúrgica versus hialuronato sódico 1% en la cirugía extracapsular de catarata310, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42620]], camposKey:0365-6691 1994-01-01 Factores clínicos que predisponen al fracaso de transplante de cornea: rechazo inmune659666, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10060]], camposKey:0146-0404 1994-01-01 PHARMACOKINETICS OF INTRAVITREAL VANCOMYCIN IN INFECTED AND UNINFECTED RABBIT EYES19071907, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=747]], camposKey:0146-0404 1994-01-01 Sensitivity of human uveal melanoma cell-lines to the type-2 ribosome-inactivating proteins (rips) ricin, ebulin-1, and nigrin-b19271927, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49656]], camposKey:0210-4806 1994-01-01 Ureteral endometriosis. Report of a case Endometriosis ureteral. A propósito de un caso.822825, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71252]], camposKey:0030-3747 1993-09-01 EFFICACY OF INTRAVITREOUS INTERLEUKIN-1 IN THE REABSORPTION OF EXPERIMENTAL VITREOUS HEMORRHAGE IN RABBITS302306, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71326]], camposKey:0146-0404 1993-03-15 COMPARISON OF THE SENSITIVITY AND SPECIFICITY OF DIAGNOSTIC-TESTS WITH AND WITHOUT TOPICAL ANESTHESIA FOR DRY EYE SYNDROME IN BLEPHARITIS919919, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71328]], camposKey:0146-0404 1993-03-15 EFFICACY OF 2-PERCENT NEDOCROMIL SODIUM COMPARED TO 2-PERCENT SODIUM CROMOGLYCATE IN A MODEL OF ALLERGIC CONJUNCTIVITIS IN THE GUINEA-PIG844844, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71324]], camposKey:0146-0404 1993-03-15 EPIDEMIOLOGIC RISK-FACTORS PREDISPOSING TO CORNEAL ALLOGRAFT FAILURE10981098, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71323]], camposKey:0146-0404 1993-03-15 INTRAVITREAL PHARMACOKINETICS OF 5-FLUOROURACIL (5-FU) IN NORMAL AND SURGICALLY TRAUMATIZED RABBIT EYES14231423, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71327]], camposKey:0146-0404 1993-03-15 PHOTOGRAPHIC BRUCKNER TEST (PBT) VALIDITY IN DETECTING AMBLYOGENIC DISEASES IN A SAMPLE BASED POPULATION861861, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71325]], camposKey:0146-0404 1993-03-15 TUMOR-NECROSIS-FACTOR (TNF) ALFA IN PROLIFERATIVE DIABETIC-RETINOPATHY (PDR)10401040, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=707]], camposKey:0161-6420 1993-03-01 SURFACE TOXICITY OF TIMOLOL - REPLY293294, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41619]], camposKey:0161-6420 1993-01-01 Authors' reply293294, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49658]], camposKey:0927-3972 1993-01-01 Detecting amblyogenic diseases with the photographic bruckner test39, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49657]], camposKey:0030-3747 1993-01-01 Efficacy of intravitreous lnterleukin-1 in the reabsorption of experimental vitreous hemorrhage in rabbits302306, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=773]], camposKey:0146-0404 1993-01-01 Enzymatic deglycosilation and electrophoretic analysis of the ocular mucus structure14691469, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13952]], camposKey:0210-1963 1993-01-01 Un nuevo aceite de silicona utilizable para el desprendimiento de retina8392, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49660]], camposKey:0365-6691 1992-12-01 Effect of intravitreal injection of platelet-rich plasma associated with cryotherapy and vitrectomy. Experimental study ESTUDIO EXPERIMENTAL DEL EFECTO DE LA INYECCION INTRAVITREA DE PLASMA RICO EN PLAQUETAS ASOCIADO A CRIOAPLICACION Y VITRECTOMIA313320, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49659]], camposKey:0365-6691 1992-12-01 Volume of eydrops use in glaucoma treatment VOLUMEN DE LAS GOTAS EMPLEADAS EN EL TRATAMIENTO DE GLAUCOMA289292, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71284]], camposKey:0001-639X 1992-10-01 INTRAVITREAL SILICONE AND FLUOROSILICONE OILS - PATHOLOGICAL FINDINGS IN RABBIT EYES651658, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71330]], camposKey:0146-0404 1992-03-15 EFFICACY AND SAFETY OF INTRACAMERAL INJECTION OF IBOPAMINE (IBO) IN RABBITS11171117, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71332]], camposKey:0146-0404 1992-03-15 EFFICACY AND TOLERANCE OF INTRAVITREAL INJECTION OF INTERLEUKIN-1 BETA (IL-1B) IN EXPERIMENTAL VITREOUS HEMORRHAGES855855, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71329]], camposKey:0146-0404 1992-03-15 IMPAIRMENT OF THE OCULAR SURFACE OF THE GUINEA-PIG AFTER LONG-TERM TOPICAL TREATMENT12411241, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71333]], camposKey:0146-0404 1992-03-15 PHARMACOKINETICS OF INTRAVITREAL 5-FLUOROURACIL (5-FU) IN THE RABBIT727727, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71331]], camposKey:0146-0404 1992-03-15 ROLE OF THE RETINOTOMY IN THE DEVELOPMENT OF AN EXPERIMENTAL-MODEL OF PROLIFERATIVE VITREORETINOPATHY (PVR)856856, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=1838]], camposKey:0021-9673 1992-01-01 Determination of 5-fluorouracil in vitreous gel and liquid by high-performance liquid chromatography183189, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=651]], camposKey:0277-3740 1992-01-01 Epidermal Growth Factor and Corneal Wound Healing: A Multicenter Study311314, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42629]], camposKey:0365-6691 1992-01-01 Estudio de las características farmacocinéticas del 5-Fluoruracilo intravítreo a partir de un modelo experimental de ojo perfundido213218, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43955]], camposKey:0365-6691 1992-01-01 Estudio experimental del efecto de la inyección intravítrea de plasma rico en plaquetas asociado a crioaplicación y vitrectomía313320, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46181]], camposKey:0365-6691 1992-01-01 Estudio inmunocitoquímico de las membranas periretinianas en un modelo experimental de vitreorretinopatía proliferante (VRP)519524, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41765]], camposKey:0030-3747 1992-01-01 Intraocular irrigating solutions and vitrectomy-related changes (In protein, lactic and ascorbic acid) in rabbit vitreous6167, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41656]], camposKey:0365-6691 1992-01-01 Intraocular tolerance of bioerodible polymers as a stand for programmed drug delivery. An experimental study Tolerancia intravítrea de polímeros biodegradables como soporte para la liberación programada de fármacos estudio experimental513518, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=35030]], camposKey:0271-3683 1992-01-01 Intravitreal and subretinal proliferation induced by platelet-rich plasma injection in rabbits10471055, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41657]], camposKey:1755-375X 1992-01-01 Intravitreal silicone and fluorosilicone oils: pathologic findings in rabbit eyes651658, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42467]], camposKey:0146-0404 1992-01-01 IS CHRONIC APPLICATION OF EYEDROPS RELATED WITH OCULAR ALLERGY850850, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=690]], camposKey:0161-6420 1992-01-01 Ocular Surface Alteration after Long-term Treatment with an Antiglaucomatous Drug10821088, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49661]], camposKey:8756-3320 1992-01-01 Reduction of Cardiovascular Side Effects Associated with Ocular Administration of Metipranolol by Inclusion in Polymeric Nanocapsules191198, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41655]], camposKey:0365-6691 1992-01-01 Studies of pharmacokinetic characteristics of intravitreous 5-fluorouracil in a perfused eye model. ESTUDIO DE LAS CARACTERISTICAS FARMACOCINETICAS DEL 5-FLUORURACILO INTRAVITREO A PARTIR DE UN MODELO EXPERIMENTAL DE OJO PERFUNDIDO213218, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42630]], camposKey:0365-6691 1992-01-01 Tolerancia intravítrea de polímeros biodegradables como soporte para la liberación programada de fármacos: estudio experimental513518, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55187]], camposKey:0365-6691 1992-01-01 Volumen de las gotas empleadas en el tratamiento del glaucoma289292, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71334]], camposKey:0146-0404 1991-03-15 A PERFUSED RABBIT EYE AS A MODEL FOR INVIVO INTRAOCULAR PHARMACOKINETIC STUDIES - CLEARANCE OF INTRAVITREAL 5-FLUOROURACIL (5-FU)12961296, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71336]], camposKey:0146-0404 1991-03-15 EFFECT OF INTRAVITREAL INJECTION OF INTERLEUKIN-1 (IL-1) IN THE REABSORPTION OF EXPERIMENTAL VITREOUS HEMORRHAGES882882, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=692]], camposKey:0146-0404 1991-03-15 ENHANCED OCULAR ANAPHYLAXIS IN THE GUINEA-PIG AFTER LONG-TERM, LOCALLY APPLIED DROPS683683, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71335]], camposKey:0146-0404 1991-03-15 INTRAOCULAR BIOERODIBLE POLYMERS AS A CONTINUOUS DRUG DELIVERY SYSTEM12931293, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55195]], camposKey:0365-6691 1991-01-01 Efecto de la instalación crónica de fármacos sobre la superficie conjuntival8996, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49663]], camposKey:0146-0404 1991-01-01 Ocular toxicity of low-molecular-weight components of silicone and fluorosilicone oils30073020, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49662]], camposKey:0271-3683 1991-01-01 Retinal cryoapplication and fibrinolysis in experimental vitreous hemorrhage697701, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3575]], camposKey:0365-6691 1991-01-01 The effect of long-term drug applications on the eye surface8996, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46192]], camposKey:1133-7737 1991-01-01 Tratamiento de la endoftalmitis mediante inyección intravítrea de antibióticos.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46185]], camposKey:0365-6691 1991-01-01 Tratamiento profiláctico de la vitreorretinopatía proliferante (VRP)315322, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46176]], camposKey:0365-6691 1990-01-01 Análisis computerizado de imágenes de la cabeza del nervio óptico como un signo precoz de detención de los cambios glaucomatosos635640, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46191]], camposKey:0365-6691 1990-01-01 Análisis de imagenes computerizado de la cabeza del nervio óptico como signo precoz de detención de los cambios glaucomatosos445450, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42627]], camposKey:0365-6691 1990-01-01 Efectos biológicos de los componentes de bajo peso molecular del aceite de silicona271276, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43957]], camposKey:0365-6691 1990-01-01 Estudio experimental de vitreorretinopatía proliferante: Comparación entre dos modelos233242, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=676]], camposKey:0146-0404 1990-01-01 Pharmacologic modulation of vascular permeability in ocular allergy in the rat176180, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46174]], camposKey:0365-6691 1990-01-01 Resultados en la cirugía del desprendimiento de retina en pacientes afáquicos: a propósito de 69 casos7984, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69978]], camposKey:0365-6691 1989-01-01 Análisis experimental de la tolerancia de distintos tipos de sustitutivos vítreos. II: Análisis con microscopía óptica.443448, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69988]], camposKey:0365-6691 1989-01-01 El efecto de la Criocoagulación en la evolución de las hemorragias intravítreas de los pacientes diabéticos.199204, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41658]], camposKey:0365-6691 1989-01-01 Experimental analysis of the tolerance of various types of vitreous body substitutes. II. Analysis by optical microscopy ANALISIS EXPERIMENTAL DE LA TOLERANCIA DE DISTINTOS TIPOS DE SUSTITUTIVOS VITREOS. II. ANALISIS CON MICROSCOPIA OPTICA443448, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69989]], camposKey:0365-6691 1989-01-01 Hemorragias en los diabéticos vitrectomizados.221226, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69994]], camposKey:0365-6691 1989-01-01 La presión del segmento posterior: estudio experimental.6770, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70004]], camposKey:0365-6691 1989-01-01 Modificaciones bioquímicas en la cavidad vítrea tras la vitrectomía.431442, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70003]], camposKey:0365-6691 1988-01-01 Análisis crítico del modelo de hipertensión ocular mediante infusión endovenosa de suero glucosado al 5 %.531540, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69931]], camposKey:0365-6691 1988-01-01 Modelo experimental de anafilaxia pasiva conjuntival: Ensayo de fármacos antialérgicos por vía tópica.3344, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69997]], camposKey:0365-6691 1987-01-01 Complicaciones de la vitrectomía.203210, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69977]], camposKey:0365-6691 1987-01-01 Edema de retina postvitrectomía. Estudio experimental.445458, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69970]], camposKey:0365-6691 1987-01-01 Efecto de la cirugía del hilo sobre las endotropías de ángulo variable.719724, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69990]], camposKey:0365-6691 1987-01-01 La hipotensión ocular obtenida por hiperventilación. Estudio experimental.285292, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69998]], camposKey:0365-6691 1987-01-01 Resultado de las inyecciones SF6 como tratamiento del desprendimiento de la retina mediante inyecciones repetidas de gas expandible y criopexia.393398, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49664]], camposKey:0271-3683 1987-01-01 Role of the intraocular irrigating solutions in the pathogenesis of the postvitrectomy retinal edema13691379, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73344]], camposKey:0212-8799 1987-01-01 Traumatismos oculares II6573, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69999]], camposKey:0365-6691 1986-01-01 Bloqueo de la respuesta hipertensiva ocular en el conejo tras infusión endovenosa de suero glucosado al 5 por 100, por indometacina.585592, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69974]], camposKey:0365-6691 1986-01-01 Incidencia de la Vitreo-Retinopatía Proliferante (VRP) en el desprendimiento de retina regmatógeno.229234, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49665]], camposKey:0365-6691 1986-01-01 Indomethacin block of the ocular hypertensive response induced in rabbits by i.v. injection of 5% glucose saline BLOQUEO DE LA RESPUESTA HIPERTENSIVE OCULAR EN EL CONEJO TRAS INFUSION ENDOVENOSA DE SUERO GLUCOSADO AL 5 POR 100, POR INDOMETACINA585591, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70006]], camposKey:0365-6691 1986-01-01 La crioterapia como tratamiento inespecífico de las hemorragias intravítreas.203208, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49666]], camposKey:0748-9501 1986-01-01 Modifications in intraocular pressure during general anestheisa - The influence of induced arterial hypotension2129, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69991]], camposKey:0365-6691 1986-01-01 Resultados de la tonografía computerizada.4550, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70000]], camposKey:0365-6691 1986-01-01 Resultados de un análisis comparativo entre dos lentes semiflexibles de cámara anterior579584, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73343]], camposKey:0212-8799 1986-01-01 Traumatismos oculares (I)377383, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69983]], camposKey:0365-6691 1985-01-01 Efecto de la hipotensión arterial controlada sobre la presión intraocular (La hipotensión en la cirugía II)4956, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69924]], camposKey:0365-6691 1985-01-01 Resultados del tratamiento con Trifluorotimidina en pacientes con herpes corneal.317322, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39183]], camposKey:0365-6691 1985-01-01 Results of trifluridine treatment in patients with corneal herpes RESULTADOS DEL TRATAMIENTO CON TRIFLUOROTIMIDINA EN PACIENTES CON HERPES CORNEAL317322, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49668]], camposKey:0365-6691 1984-01-01 Double blind trial of dipivefrine and epinephrine bitartrate ESTUDIO DOBLE CIEGO DE LA DIPIVALYL EPINEFRINA Y EL BITARTRATO DE EPINEFRINA15, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69996]], camposKey:0365-6691 1984-01-01 Estudio doble ciego de la Dipivalyl Epinefrina y el Bitartrato de Epinefrina16, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49667]], camposKey:0365-6691 1984-01-01 Methylcellulose cylinders (slow-release artificial tears) in dry-eye syndromes UTILIDAD DE UNOS CILINDROS DE METILCELULOSA EN LOS SINDROMES DE OJO SECO435440, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69995]], camposKey:0365-6691 1984-01-01 Utilidad de unos cilindros de metilcelulosa en los síndromes de ojo seco435440, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69993]], camposKey:0365-6691 1983-01-01 El glaucoma neurovascular. Profilaxis y tratamiento136, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70002]], camposKey:0365-6691 1982-01-01 Encuesta de opinión sobre aspectos docentes de la Oftalmología238246, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70001]], camposKey:0365-6691 1982-01-01 Glaucoma por células fantasmas. Presentación de un caso.174179, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69925]], camposKey:0365-6691 1982-01-01 Melanosis precancerosa : A propósito de un caso.359362, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52804]], camposKey:0081-1270 1982-01-01 Modele mathematique de dyssynergie Mathematical model of dyssynergia231234, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69985]], camposKey:0365-6691 1981-01-01 Comentarios sobre una experiencia docente557564, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69984]], camposKey:0365-6691 1981-01-01 Interés clínico de la electrooculografía dinámica490502, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49672]], camposKey:0556-6177 1980-03-01 Diabetic retinopathy. Prevention and social problems Retinopatía diabética. Problemas sociales y profilaxis.4041, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13953]], camposKey:0211-2698 1980-01-01 Anomalía de Peters6066, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49669]], camposKey:0556-6177 1980-01-01 Diabetic retinopathy. Classification Retinopatía diabética. Classificacion.1617, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49673]], camposKey:0556-6177 1980-01-01 Diabetic retinopathy. Concept Retinopatía diabética. Concepto.150, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49674]], camposKey:0556-6177 1980-01-01 Diabetic retinopathy. Elemental lesions Retinopatía diabética. Lesiones elementales.2632, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49675]], camposKey:0556-6177 1980-01-01 Diabetic retinopathy. Occurrence Retinopatía diabética. Incidencia.1820, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49671]], camposKey:0556-6177 1980-01-01 Diabetic retinopathy. Pathological anatomy. Pathohenesis Retinopatía diabética. Anatomía patológica. Patogenia.2125, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49670]], camposKey:0556-6177 1980-01-01 Diabetic retinopathy Retinopatía diabética.1325, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49676]], camposKey:0556-6177 1980-01-01 Diabetic retinopathy. Treatment Retinopatía diabética. Tratamiento.339, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70005]], camposKey:0365-6691 1980-01-01 Efectos del maleato de timolol en el glaucoma de ángulo abierto. Resultados de un estudio doble ciego con la Pilocarpina y estudio a largo plazo (9 meses)12171227, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49677]], camposKey:0365-6691 1980-01-01 Effects of timolol maleate in open-angle glaucoma. Results of a double-blind trial against pilocarpine and a long term study (9 months) EFECTOS DEL MALEATO DE TIMOLOL EN EL GLAUCOMA DE ANGULO ABIERTO. RESULTADOS DE UN ESTUDIO DOBLE CIEGO CON LA PILOCARPINA Y ESTUDIO A LARGO PLAZO (9 MESES)12171227, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69987]], camposKey:0365-6691 1980-01-01 El diabético de alto riesgo.: Estudio epidemiológico de la microangiopatía retiniana en 500 diabéticos103114, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69986]], camposKey:0365-6691 1980-01-01 El valor de las exploraciones rutinarias en el diagnóstico etiológico de las uveítis1827, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69992]], camposKey:0365-6691 1980-01-01 Pliegues coroideos12951305, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70007]], camposKey:0365-6691 1980-01-01 Retinopatía diabética proliferante833841, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13983]], camposKey:0365-6691 1979-01-01 Alteraciones funcionales oculares en relación con la retinopatía diabética204213, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13982]], camposKey:0365-6691 1979-01-01 El electroretinograma y el potencial evocado visual en los diabéticos709723, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13977]], camposKey:0365-6691 1979-01-01 Evolución a largo plazo (dos años) de la trabeculectomía290298, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13955]], camposKey:0210-0681 1979-01-01 Glaucoma traumático327337, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13954]], camposKey:0211-2698 1979-01-01 Un caso de retinopatía pigmentosa y drusas del nervio óptico2330, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49678]], camposKey:0365-6691 1978-01-01 Asymmetric response to the dexamethasone test in a diabetic RESPUESTA ASIMETRICA AL TEST DE LA DEXAMETASONA EN UNA DIABETICA3135, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13979]], camposKey:0365-6691 1978-01-01 Depresión de la cortical anterior. Complicación de una trabeculectomía569572, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49679]], camposKey:0365-6691 1978-01-01 Embryonal rhabdomyosarcoma of the orbit in a man aged 23 years RABDOMIOSARCOMA EMBRIONARIO ORBITARIO EN UN VARON DE 23 ANOS861869, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13978]], camposKey:0365-6691 1978-01-01 Enfermedad de Stargardt con corona perimacular e integridad de la región macular277284, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13980]], camposKey:0365-6691 1978-01-01 Fracasos de la trabeculectomía12211228, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13981]], camposKey:0365-6691 1978-01-01 Pulso retiniano transitorio en un segmento arteriolar13291334, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55193]], camposKey:0365-6691 1978-01-01 Rabdomiosarcoma embrionario orbitario en un varón de 23 años861870, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13975]], camposKey:0365-6691 1977-01-01 Patología del tejido clásico de la membrana de Bruch. A propósito de dos casos507522, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13974]], camposKey:0365-6691 1976-01-01 El valor de la electrorretinografía clásica en el estudio de la retinopatía diabética465474, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13956]], camposKey:0210-0681 1976-01-01 Epidemiología de la retinopatía diabética615633, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13973]], camposKey:0365-6691 1976-01-01 La trabeculectomía11751186, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55188]], camposKey:0365-6691 1975-01-01 Las hemorragias retinianas (H. R.) en los recién nacidos235244, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49681]], camposKey:0365-6691 1975-01-01 Retinal bleedings in newborns LAS HEMORRAGIAS RETINIANAS (H.R.) EN LOS RECIEN NACIDOS235244, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49680]], camposKey:0556-6177 1975-01-01 Ulceras corneales como complicacion de la anestesia general Corneal ulcer as a complication of general anesthesia121127, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55191]], camposKey:0365-6691 1974-01-01 Malformaciones oculares múltiples de origen familiar471478, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49682]], camposKey:0365-6691 1974-01-01 Multiple ocular malformations of familial origin MALFORMACIONES OCULARES MULTIPLES DE ORIGEN FAMILIAR471478, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49683]], camposKey:0040-8867 1974-01-01 Retinal bleeding in the newborn HEMORRAGIAS RETINIANAS (H.R.) EN EL RECIEN NACIDO10491060, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49684]], camposKey:0556-6177 1973-01-01 Considerations on a case of trachoma CONSIDERACIONES SOBRE UN CASO DE TRACOMA345349, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49685]], camposKey:0365-6691 1973-01-01 Personal cases of diplopia in the surgery of retinal detachment NUESTRA INCIDENCIA DE DIPLOPIAS EN LA CIRUGIA DEL DESPRENDIMIENTO DE RETINA971984, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49686]], camposKey:0556-6177 1972-01-01 Development of a hypertensive retinopathy after hemodialysis and renal transplantation. Report of a case Evolución de una retinopatía hipertensiva tras hemodiálisis y trasplante renal. Presentación de un caso277281][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=3437]},camposKey: 17 27 Afectación del campo visual en la baja visión: pérdida de campo central y periférico y defectos neurológicos 8498358493Manual de Baja Visión y Rehabilitación Visual 1 null Editorial Médica Panamericana , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=19670]},camposKey: 460 470 Capítulo 25. Cirugía Vitreorretiniana en los traumatismos oculares. Sección 25E. Tamponadores, manipuladores y tinciones en la cirugía del traumatismo ocular 978-84-89085-68-8Traumatología ocular 1 2018-01-01 Sociedad Española de Oftalmología, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=17582]},camposKey: 11 23 Pathogenesis, histopathology, and classification 978-331978445-8Retinal Detachment Surgery and Proliferative Vitreoretinopathy 1 2018-01-01 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=28772]},camposKey: 406 0 Programa de cribado de retinopatía diabética: Grado de satisfacción y conocimiento previo de lospacientes 978-84-09-07462-4XXII Encuentro Internacional de Investigación en Cuidados 1 2018-01-01 Instituto de Salud Carlos III , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=17583]},camposKey: 325 332 PVR Detachment questionnaire: Part 1 978-331978445-8Retinal Detachment Surgery and Proliferative Vitreoretinopathy 1 2018-01-01 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=17585]},camposKey: 333 357 PVR detachment questionnaire: Part 2 978-331978445-8Retinal Detachment Surgery and Proliferative Vitreoretinopathy 1 2018-01-01 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=17584]},camposKey: 359 383 PVR detachment questionnaire: Part 3 978-331978445-8Retinal Detachment Surgery and Proliferative Vitreoretinopathy 1 2018-01-01 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=17586]},camposKey: 241 255 Vitreoretinal surgeons assess surgical cases: A questionnaire 978-331978445-8Retinal Detachment Surgery and Proliferative Vitreoretinopathy 1 2018-01-01 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=3439]},camposKey: 28 38 App Móvil de ayuda a la decisión para el aprendizaje de la asignatura "Oftalmología" en el Grado de Medicina de la Universidad de Valladolid 9492805006Propuestas de innovación educativa en la sociedad de la información 1 2017-07-31 Adaya Press , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=3440]},camposKey: 494 501 Aprendiendo oftalmología a través de una app móvil 978-84-617-7628-3EDUNOVATIC 2016 - I Congreso Virtual internacional de Educación, Innovación y TIC.: Del 14 al 16 de diciembre de 2016. Libro de actas 1 2016-01-01 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=19013]},camposKey: Evaluating the QoE of a mobile DSS for diagnosis of red eye diseases by medical students 978-150903370-62016 IEEE 18th International Conference on e-Health Networking, Applications and Services (Healthcom) : 14-16 Sept. 2016 1 2016-01-01 Institute of Electrical and Electronics Engineers Inc., CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=3438]},camposKey: 68 69 Seguridad y tolerancia de la inyección intravítrea de células madre mesenquimales en conejos 8497737342Actas del XX Congreso Internacional de la Sociedad Española de Cirugía Veterinaria (SECIVE), Facultad de Veterinaria, Universidad de León 19-20 junio de 2015 1 2015-01-01 Servicio de Publicaciones , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=17065]},camposKey: 41 51 Diabetic Retinopathy: An Overview 0124017177Handbook of Nutrition, Diet and the Eye 1 2014-01-01 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=14831]},camposKey: 214 239 Discrete portable measuring device for monitoring noninvasive intraocular pressure with a nano-structured sensing contact lens prototype 9781466627949Digital Advances in Medicine, E-Health, and Communication Technologies 1 2013-01-01 IGI Global, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=19014]},camposKey: Hybrid contact lens capable of intraocular pressure monitoring in noninvasive way 9781467359818The 17th International Conference on Solid-State Sensors, Actuators and Microsystems : TRANSDUCERS'2013 Barcelona & EUROSENSORS XXVII / IEEE, Electron Devices Society 1 2013-01-01 IEEE, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=17587]},camposKey: 237 256 Vitrectomy for diabetic retinopathy 9814304433Diabetic Retinopathy 1 2010-01-01 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=13800]},camposKey: 27 36 Importancia de las alteraciones visuales en los niños en edad escolar. Su detección 8479034890Problemas médicos en la escuela y su entorno 1 1999-01-01 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=29526]},camposKey: 33 39 Alteraciones visuales más importantes en los niños: detección en la escuela 8477627592Problemas médicos en la escuela y su entorno 1 1997-01-01 Servicio de apoyo a la enseñanza (Antiguo ICE) ][][Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=122827],camposKey=8448175395Guiones de Oftlamologia 1 2011-10-27 McGraw-Hill Interamericana de España}, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=122835],camposKey=8448602102Guiones de oftalmología 1 1998-06-01 McGraw-Hill Interamericana de España}, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=102649],camposKey=84-8498-482-6Diagnóstico precoz del glaucoma: LXXIII ponencia de la Sociedad Española de Oftalmología 1 1997-01-01 }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=102641],camposKey=84-486-0193-9La refracción en el niño 1 1997-01-01 McGraw-Hill Interamericana de España}, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=102643],camposKey=84-486-0131-9Endoftalmitis: formas clínicas, diagnóstico y tratamiento 1 1996-01-01 McGraw-Hill Interamericana de España}, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=102642],camposKey=84-7762-230-2Complicaciones del tratamiento del glaucoma 1 1991-01-01 }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=102645],camposKey=84-7592-368-2Anestesia en oftalmología 1 1990-01-01 }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=102647],camposKey=84-7592-119-1Endoftalmitis 1 1989-01-01 }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=102646],camposKey=84-7092-234-3Retinopatía diabética 1 1982-01-01 }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=102644],camposKey=84-313-0228-3Oftalmología 1 1976-01-01 Ediciones Universidad de Navarra. EUNSA}][][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63534]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64735]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62324]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62325]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62391]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63838]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63712]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63759]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56920]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64105]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56864]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56813]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56823]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56908]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56807]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56897]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56898]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63534]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64735]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62324]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62325]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62391]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63838]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63712]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63759]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56920]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64105]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56864]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56813]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56823]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56908]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56807]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56897]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56898]]][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30474]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638977]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638332]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145637387]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638836]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636984]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145637303]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145627876]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636594]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145631287]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145632938]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145633998]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145629717]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145630289]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145625122]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145629335]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145627401]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626869]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626865]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145627428]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626864]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626871]]][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@52500963, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2d1b4fa5, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@600899f9, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@16f74d97, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@44be453b, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@33af4c6e, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@17ccdcb3, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3bfba028, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@ddaadf1][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601a5c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@602475, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601b8a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601b61, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601b1f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6024dd, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601cc8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601c47, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601c3b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601b5c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601d03, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@602328, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3bf147, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601004, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601b18, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60235c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6023de, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601aeb, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60236a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@602495, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@602436, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@600ee5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6023c9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6022d2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@600e5b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@602513, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60105c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@602360, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@600dc5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3750ed, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601fb7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601037, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60226b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601115, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@600e1b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5d3cf7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601edc, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601d8d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601f96, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6010a1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601fb9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60125d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601234, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601d8f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601e72, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601fc7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601d9c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60111c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601ed0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601e7c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601e05, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60121d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601de2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601eb7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601dd4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373a74, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@602017, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601c1f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3739f7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601dce, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6010f9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601127, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6019e5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373a45, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60199a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6021de, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5d3d07, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d71ec, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@602122, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373aab, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60210f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6019c1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373a96, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60199c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6021e5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6021e8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6021d0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@602033, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60185d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601c32, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373391, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6021d8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601b70, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601c50, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6022b7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60188a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37521f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601255, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373c3f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601315, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601c58, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601805, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b8a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601651, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373dee, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601642, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373260, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601ef2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60142e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601ef1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b3e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373cc6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3726f7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601440, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601ce2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@600ed2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601835, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372d79, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372be2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372c6f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373ecf, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372293, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6017f8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6013f0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6013e3, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372be1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372bc5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372342, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372afa, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601041, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372bf7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3726e8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6012b7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601bb1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6016e5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3729f2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372202, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372d88, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6014c4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601f1b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601f1a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601951, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3730ff, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6013df, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6012f7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601e5e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6012f6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372a3e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373142, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60149f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601470, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6018d7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601d7c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3724a9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60135f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373140, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3722f0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601393, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6014d1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@602052, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373141, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3722e9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@602257, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6014df, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6014e3, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d26, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37294d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37300c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373afd, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372ea5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60205e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601e3f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@602219, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37294b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b83, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b81, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d07, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d06, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d6c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372ea6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d6f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372949, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372931, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b92, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373ae7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373cd6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373bb9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b3d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37523f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6013c2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6013f1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6013c3, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60132a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6020c7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601ce3, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d6d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372eec, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6012cf, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6013c1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6013c0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601369, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60204a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@602254, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60222e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60224f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37523d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601b7f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6020c6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372948, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601b80, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601426, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@601425, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@60142f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6014c3, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6014a6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373c2c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d76, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d75, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d5a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6013e0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@375242, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b39, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373ce8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@375241, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372947, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d59, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d78, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d74, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37523e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b94, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373aed, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d0c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b82, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@375244, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3730d4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372acc, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d8f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b93, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@375243, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373aec, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@375240, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372ca0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372257, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b0c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b99, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3734b8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3734d4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373ae8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b19, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3734f7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373e55][][][com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.gpc.GpcEstadesForaPK[ifcactivitat=ESF, ifccomptador=56888]]][com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.gpc.GpcEstadesForaPK[ifcactivitat=ESF, ifccomptador=56888]]][][com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1460]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1301]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1093]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1090]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1092]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1091]]][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@56fe39], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4662cb], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4617f6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c25], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45eea9], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5bf741], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@414d42], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5bf74c], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4132c6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41335c], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413397], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41316b], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5bf720], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5bf6c5], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4131c3], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5bf734], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413eac], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413f45], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413f7c], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4124c6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@414002], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4125d8], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413bdc], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412450], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4136a9], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412533], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@56f7c7], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412466], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412fca], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413ee8], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41247e], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413ef9], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4122f5], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412123], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4122a6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41235e], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4122eb], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41231b], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413e02], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411db1], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412300], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4122f7], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4605c0], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411e7c], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41219b], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411b70], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460462], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@46035f], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4127be], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4135f2], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f47d], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f45f], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4134db], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41346c], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413522], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4134f7]][][CatedrasConvenios{id=13, codigoPersona=com.sigma.fs3.argos.domain.gpc.PersonalGPC[ifcidPers=22014], codigoTipo=CAT, codigoContable=null, titulo=CATEDRA NOVARTIS, fechaInicio=2020-10-29, fechaFin=null, importe=60544.05, visiblePortal=1, visibleCvn=1, visibleMemoria=1, validado=S}, CatedrasConvenios{id=5, codigoPersona=com.sigma.fs3.argos.domain.gpc.PersonalGPC[ifcidPers=22014], codigoTipo=CAT, codigoContable=null, titulo=CÁTEDRA ALCÓN DE LA UNIVERSIDAD DE VALLADOLID, fechaInicio=2010-02-25, fechaFin=null, importe=13014.21, visiblePortal=1, visibleCvn=1, visibleMemoria=1, validado=S}, CatedrasConvenios{id=17, codigoPersona=com.sigma.fs3.argos.domain.gpc.PersonalGPC[ifcidPers=22014], codigoTipo=CAT, codigoContable=null, titulo=CÁTEDRA TOPCON DE TECNOLOGÍA OFTÁLMICA EN LA UNIVERSIDAD DE VALLADOLID , fechaInicio=2008-09-25, fechaFin=null, importe=11990.0, visiblePortal=1, visibleCvn=1, visibleMemoria=1, validado=S}][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@15e77, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1581f, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@15853, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@155c2, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1531d, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14cf2, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14088, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@142e9, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@13c5c, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14806, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@13c54, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14810, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@142a8][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=31131]},camposKey: 43 0 Caracterización de la autofagia en un modelo in-vitro deneurodegeneración retiniana 8412292766La madre de los aires 1 2021-01-01 Fundación 3CIN , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=31130]},camposKey: 86 0 Evaluación de la necroptosis en un modelo organotípico e neurodegeneración retiniana 8412292766La madre de los aires 1 2021-01-01 Fundación 3CIN , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=25903]},camposKey: 73 93 Medida de la PIO con nuevos sensores de lentes de contacto 84-943550-5-8Temas actuales en Optometría. SIYO 2014 1 2016-01-01 Ediciones MC]

PUBLICACIONES

Artículos de revista (470)


Enlace a la publicación
Ver Todos

Libros (10)

Maldonado Lopez, Miguel J.; Pastor Jimeno, Jose Carlos. Guiones de Oftlamologia. McGraw-Hill Interamericana de España; 2011.
Ver Todos

Capítulos de libros (18)

Pastor Jimeno, Jose Carlos. Afectación del campo visual en la baja visión: pérdida de campo central y periférico y defectos neurológicos . En: -. Manual de Baja Visión y Rehabilitación Visual. Editorial Médica Panamericana p. 17-27.


Ver Todos

Actas de congresos (3)

Galindo Cabello, N.; Hernandez Rodriguez, L.A; Puertas Neyra, K.; Pastor Jimeno, Jose Carlos; Fernandez Bueno, Ivan; Usategui Martin, Ricardo (2021). Caracterización de la autofagia en un modelo in-vitro deneurodegeneración retiniana . En -. La madre de los aires. 1 ed. Fundación 3CIN 2021. p. 43.

Ver Todos
 

AYUDA A LA INVESTIGACIÓN

Proyectos (56)

DISEÑO, DESARROLLO Y VALIDACIÓN DE UN PERFLUROOOCTANO ALTAMENTE PURIFICADO PARA USO EN CIRUGÍA OFTALMOLÓGICA: JUSTPERFLUORO. Equipo Investigadores: FERNANDEZ BUENO, IVAN (IP); PASTOR JIMENO, JOSE CARLOS; GARCIA SERNA, JUAN; CANTERO SPOSETTI, DANILO ALBERTO. Personal Contratado: GALLEGO GUERRA, SILVIA TERESA. CPP2021-008695. Entidades colaboradoras AJL OPHTHALMIC SA , VISION I+D, S.L.. Entidades Participantes: UNIVERSIDAD DE VALLADOLID (UVa). Entidades Financiadoras: AGENCIA ESTATAL DE INVESTIGACIÓN, 10.13039/501100011033, UNIÓN EUROPEA.-NEXT GENERATION UE, PLAN DE RECUPERACIÓN, TRANSFORMACIÓN Y RESILIENCIA, MICINN. MINISTERIO DE CIENCIA E INNOVACIÓN . 01/03/2022-28/02/2025

Next Generation-UEMnisterio de Ciencia e InnovaciónAEIPlan de Recuperación, transformación y Resiliencia
Ver Todos

Convenios/Contratos OTC (241)

CENTRO EN RED DE MEDICINA REGENERATIVA Y TERAPIA CELULAR DE CYL.. Equipo Investigadores: PASTOR JIMENO, JOSE CARLOS (IP). Entidades Participantes: FUNDACION GENERAL DE LA UNIVERSIDAD DE VALLADOLID.. Entidades Financiadoras: JUNTA DE CASTILLA Y LEÓN.. 01/01/2024

Ver Todos

Otras ayudas y becas (17)

CONTRATO GARANTÍA JUVENIL JCYL TIPO B (TITULADO) DE BALNCO SANTERO, JAVIER: Gestión y mantenimiento de un laboratorio de investigación; mantenimiento ypreparación de los equipos de trabajo; planificación y ejecución de experimentos (desarrollo de cultivos celulares y tisulares, procesamiento demuestras celulares y tisulares, desarrollo de técnicas de biología molecular); desarrollo de técnicas histológicas e inmunoquímicas; desarrollo detécnicas de análisis químicos; obtención e interpretación de resultados. PASTOR JIMENO, JOSE CARLOS (Director). BLANCO SANTERO, JAVIER (Beneficiario). 17/05/2021 - 01/12/2022. 37.000,00 EUR.

JCYL-2FSEIniciativa Empleo Juvenil-FSE
Ver Todos
 

OTROS

Tesis doctorales (22)


 
Ver Todos

Congresos (9)

ARVO 2017, BALTIMORE ( ESTADOS UNIDOS DE AMÉRICA ) 01/01/2017 -
(Asistencia). PASTOR JIMENO, JOSE CARLOS. ARVO 2017
Ver Todos

Patentes (6)

SINGH, Amar Kumar SRIVASTAVA, Girish Kumar IVAN FERNANDEZ BUENO MANUEL JOSE GAYOSO RODRIGUEZ JOSE CARLOS PASTOR JIMENO. COMPOSICIÓN FARMACÉUTICA PARA EL TRATAMIENTO Y/O PREVENCIÓN DE ENFERMEDADES RETINIANAS DEGENERATIVAS. P201331743
Ver Todos

Estancias de investigación (1)

MOVILIDAD DE ESTUDIANTES EN MÁSTERES OFICIALES "MÁSTER EN INVESTIGACIÓN EN CIENCIAS DE LA VISIÓN". 01/10/2007 - 30/09/2008


Ver Todos

Proyectos de innovación docente (13)

Transformación a la docencia y evaluación online de la asignatura Elementos Básicos de la Investigación - PID2020/042. Universidad de Valladolid. 01/09/2020.
Ver Todos

Cátedras (3)

CATEDRA NOVARTIS. Comisión Mixta Seguimiento: PASTOR JIMENO, JOSE CARLOS (Director). Entidades Participantes: NOVARTIS FARMACEUTICA, SA. 29/10/2020
Ver Todos
Cargando información ...
Universidad de Valladolid - Copyright Universidad de Valladolid - Todos los derechos reservados